Consecutive case series with long-term follow-up of full macular translocation for myopic choroidal neovascularisation

Abstract

FMT for mCNV maintained the improvement in VA for more than 5 years. However, postoperative complications and progression of chorioretinal atrophy due to myopia still seem to limit the visual improvement after FMT for mCNV.

Current and emerging treatment options for myopic choroidal neovascularization

“…Nonetheless, in very select cases of mCNV refractory to anti-VEGF therapy, MT may be useful. Recently, Sakimoto et al 11 have reported the long-term effects of MT in a large consecutive case series of 60 eyes with mCNV that underwent MT (mean follow-up period: 76.3 months). They showed that the logarithm of the minimum angle of resolution (logMAR) BCVA values at 1 year, 3 years, and 5 years postoperatively significantly ( P <0.001) improved to 0.54 at 1 year and then remained stable.…”

Highlights from this issue

“…Sakimoto2 and colleagues report 60 eyes with a mean of 72 months follow-up after full macular translocation for myopic choroidal neovascularization. There was a significant improvement in the logMAR best corrected visual acuity from 0.78 to 0.54, 0.57 and 0.61 at 1, 3 and 5 years respectively.…”